OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273
Samuel M. Ailsworth, Behnam Keshavarz, Nathan E. Richards, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 1, pp. 67-73
Open Access | Times Cited: 18
Samuel M. Ailsworth, Behnam Keshavarz, Nathan E. Richards, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 1, pp. 67-73
Open Access | Times Cited: 18
Showing 18 citing articles:
Durability of immune responses to mRNA booster vaccination against COVID-19
Prabhu S. Arunachalam, Lilin Lai, Hady Samaha, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 10
Open Access | Times Cited: 54
Prabhu S. Arunachalam, Lilin Lai, Hady Samaha, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 10
Open Access | Times Cited: 54
Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases
Michelle W. Cheung, Roya M. Dayam, Janna R. Shapiro, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 3, pp. 351-364
Open Access | Times Cited: 23
Michelle W. Cheung, Roya M. Dayam, Janna R. Shapiro, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 3, pp. 351-364
Open Access | Times Cited: 23
Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination
Jimmie Bullock, Thomas E. Hickey, Troy J. Kemp, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 516-516
Open Access | Times Cited: 5
Jimmie Bullock, Thomas E. Hickey, Troy J. Kemp, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 516-516
Open Access | Times Cited: 5
Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116704-116704
Closed Access | Times Cited: 4
Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116704-116704
Closed Access | Times Cited: 4
Mix-and-match COVID-19 vaccines trigger high antibody response after the third dose vaccine in Moroccan health care workers
Houda Amellal, Najlaa Assaid, Khadija Akarid, et al.
Vaccine X (2023) Vol. 14, pp. 100288-100288
Open Access | Times Cited: 5
Houda Amellal, Najlaa Assaid, Khadija Akarid, et al.
Vaccine X (2023) Vol. 14, pp. 100288-100288
Open Access | Times Cited: 5
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients
Yusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 725-733
Closed Access | Times Cited: 5
Yusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 725-733
Closed Access | Times Cited: 5
Mammalian Meat Allergy and IgE to Alpha-Gal in Central Virginia: Findings From a COVID-19 Vaccine and Patient Cohort
Nathan E. Richards, Samuel M. Ailsworth, Lisa J. Workman, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 10, pp. 2817-2825.e2
Closed Access | Times Cited: 1
Nathan E. Richards, Samuel M. Ailsworth, Lisa J. Workman, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 10, pp. 2817-2825.e2
Closed Access | Times Cited: 1
Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune Responses
Engin Berber, Ted M. Ross
Vaccines (2024) Vol. 12, Iss. 11, pp. 1284-1284
Open Access | Times Cited: 1
Engin Berber, Ted M. Ross
Vaccines (2024) Vol. 12, Iss. 11, pp. 1284-1284
Open Access | Times Cited: 1
Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy
Eleonora Russo, Simona Corrao, Francesca Di Gaudio, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1664-1664
Open Access | Times Cited: 4
Eleonora Russo, Simona Corrao, Francesca Di Gaudio, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1664-1664
Open Access | Times Cited: 4
Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients
Michelle W. Cheung, Roya Monica Dayam, Janna R. Shapiro, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Michelle W. Cheung, Roya Monica Dayam, Janna R. Shapiro, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Durability of immune responses to the booster mRNA vaccination against COVID-19
Prabhu S. Arunachalam, Lilin Lai, Hady Samaha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Prabhu S. Arunachalam, Lilin Lai, Hady Samaha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Effects of the induction of humoral and cellular immunity by third vaccination for SARS-CoV-2
Goh Murayama, Makio Kusaoi, Yuki Horiuchi, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 10, pp. 1021-1027
Closed Access
Goh Murayama, Makio Kusaoi, Yuki Horiuchi, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 10, pp. 1021-1027
Closed Access
Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2
Nagashige Shimada, Satoshi Sugawa, Satoshi Murakami, et al.
Vaccine X (2024) Vol. 19, pp. 100518-100518
Open Access
Nagashige Shimada, Satoshi Sugawa, Satoshi Murakami, et al.
Vaccine X (2024) Vol. 19, pp. 100518-100518
Open Access
Durability of SARS-CoV-2 IgG Antibodies: Insights from a Longitudinal Study, Puerto Rico
Zachary J. Madewell, Nathan Graff, Velma K. Lopez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Zachary J. Madewell, Nathan Graff, Velma K. Lopez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Post-pandemic, long COVID persists
Donald Y.M. Leung
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 489-490
Closed Access
Donald Y.M. Leung
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 489-490
Closed Access
Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico
Zachary J. Madewell, Nathan Graff, Velma K. Lopez, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Zachary J. Madewell, Nathan Graff, Velma K. Lopez, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Waning vaccine immunity- What is it headed for?
Lalit Gupta
Indian Journal of Clinical Anaesthesia (2023) Vol. 10, Iss. 1, pp. 1-2
Open Access | Times Cited: 1
Lalit Gupta
Indian Journal of Clinical Anaesthesia (2023) Vol. 10, Iss. 1, pp. 1-2
Open Access | Times Cited: 1
Factors Associated with Humoral Immune Response Following the Third Dose of the BNT162b2 Received by Employees at a Health–Care Facility
Patrik Palacka, Alena Rajnochová Svobodová, Lucia Skokanová, et al.
(2023)
Open Access | Times Cited: 1
Patrik Palacka, Alena Rajnochová Svobodová, Lucia Skokanová, et al.
(2023)
Open Access | Times Cited: 1
